{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:30:01Z","timestamp":1773282601340,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejmech.2022.114359","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T01:51:42Z","timestamp":1649901102000},"page":"114359","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil"],"prefix":"10.1016","volume":"237","author":[{"given":"Elena","family":"Bechthold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Schepmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantin","family":"Daniliuc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiscard","family":"Seebohm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9030-8417","authenticated-orcid":false,"given":"Bernhard","family":"W\u00fcnsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5104","key":"10.1016\/j.ejmech.2022.114359_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.8096653","article-title":"Modulation of neuronal migration by NMDA receptors","volume":"260","author":"Komuro","year":"1993","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ejmech.2022.114359_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0036853","article-title":"Overstimulation of NMDA receptors impairs early brain development in vivo","volume":"7","author":"Aida","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2022.114359_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/349156a0","article-title":"Long-term potentiation of NMDA receptor-mediated synaptic transmission in the Hippocampus","volume":"349","author":"Bashir","year":"1991","journal-title":"Nature"},{"issue":"6149","key":"10.1016\/j.ejmech.2022.114359_bib4","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/330649a0","article-title":"Long-term potentiation and NMDA receptors in rat visual cortex","volume":"330","author":"Artola","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114359_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3940(85)90069-2","article-title":"Glutamate neurotoxicity in cortical cell culture","volume":"58","author":"Choi","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2022.114359_bib6","volume":"vol. 7","author":"Choi","year":"1987"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114359_bib7","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1523\/JNEUROSCI.14-11-06317.1994","article-title":"Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson \u2019 s disease , alzheimer \u2019 s disease , and mixed Parkinson \u2019 s disease\/alzheimer \u2019 s disease patients : an autoradiographic study","volume":"14","author":"Ulas","year":"1994","journal-title":"J. Neurosci."},{"issue":"38","key":"10.1016\/j.ejmech.2022.114359_bib8","doi-asserted-by":"crossref","first-page":"28079","DOI":"10.1074\/jbc.M605081200","article-title":"SS-Amyloid-Induced dynamin 1 degradation is mediated by N -methyl- D -aspartate receptors in hippocampal neurons","volume":"281","author":"Kelly","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114359_bib9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nn.2447","article-title":"Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes","volume":"13","author":"Belforte","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6187","key":"10.1016\/j.ejmech.2022.114359_bib10","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1251915","article-title":"Crystal structure of a heterotetrameric NMDA receptor ion channel","volume":"344","author":"Karakas","year":"2014","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejmech.2022.114359_bib11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2022.114359_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.neuropharm.2013.01.016","article-title":"Influence of GluN2 subunit identity on NMDA receptor function","volume":"74","author":"Wyllie","year":"2013","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114359_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuron.2014.03.030","article-title":"Extrasynaptic NMDA receptor involvement in central nervous system disorders","volume":"82","author":"Parsons","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2022.114359_bib14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.alcohol.2016.07.005","article-title":"Reduced ethanol drinking following selective cortical interneuron deletion of the GluN2B NMDA receptors subunit","volume":"58","author":"Radke","year":"2017","journal-title":"Alcohol"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114359_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0306-4522(00)00405-X","article-title":"Molecular evidence for the involvement of NR2B subunit containing N-Methyl-D-Aspartate receptors in the development of morphine-induced place preference","volume":"101","author":"Narita","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2022.114359_bib16","first-page":"1992","article-title":"Synthesis and pharmacological properties of a series of 2-piperidino alkanol derivatives","volume":"12","author":"Carron","year":"1971","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114359_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.expneurol.2004.05.004","article-title":"The NR2B-selective NMDA receptor antagonist CP-101,606 exacerbates L-DOPA-induced dyskinesia and provides mild potentiation of anti-parkinsonian effects of L-DOPA in the MPTP-lesioned marmoset model of Parkinson's disease","volume":"188","author":"Nash","year":"2004","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2022.114359_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0304-3940(90)90408-2","article-title":"Ifenprodil and SL 82.0715 potently inhibit binding of [3H](+)-3-PPP to \u03c3 binding sites in rat brain","volume":"116","author":"Contreras","year":"1990","journal-title":"Neurosci. Lett."},{"issue":"10","key":"10.1016\/j.ejmech.2022.114359_bib19","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1021\/jm00114a018","article-title":"Separation of \u03911Adrenergic and N-Methyl-D-Aspartate antagonist activity in a series of ifenprodil compounds","volume":"34","author":"Chenard","year":"1991","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114359_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/0091270009336735","article-title":"Single-dose administration of MK-0657, an NR2B-selective NMDA antagonist, does not result in clinically meaningful improvement in motor function in patients with moderate Parkinson's disease","volume":"49","author":"Addy","year":"2009","journal-title":"J. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejmech.2022.114359_bib21","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.1016\/j.bmc.2010.09.026","article-title":"Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols","volume":"18","author":"Tewes","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114359_bib22","series-title":"2-Piperidino-1-Alkanol Derivatives as Antiischemic Agents","author":"Chenard","year":"1990"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114359_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(97)13422-X","article-title":"Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A\/NR2A and NR1A\/NR2B receptors expressed in Xenopus oocytes","volume":"223","author":"Avenet","year":"1997","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114359_bib24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0022-3565(25)13281-3","article-title":"Evidence for efficacy in models of focal cerebral lschemia","volume":"247","author":"Gotti","year":"1988","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2022.114359_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0014-2999(94)90142-2","article-title":"The NMDA receptor antagonist eliprodil (SL 82.0715) blocks voltage-operated Ca 2+ channels in rat cultured cortical neurons","volume":"257","author":"Biton","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114359_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114113","article-title":"Synthesis of tropane-based \u03a31 receptor antagonists with antiallodynic activity","volume":"230","author":"Bechthold","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114359_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/anie.198205671","article-title":"Basic principles of the CIP\u2010system and proposals for a revision","volume":"21","author":"Prelog","year":"1982","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2022.114359_bib28","unstructured":"Hellwich, K.-H.; Siebert, C. D. \u00dcbungen Zur Stereochemie; Springer Berlin Heidelberg."},{"issue":"21","key":"10.1016\/j.ejmech.2022.114359_bib29","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1016\/S0960-894X(03)00708-X","article-title":"Indole-2-Carboxamides as novel NR2B selective NMDA receptor antagonists","volume":"13","author":"Borza","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114359_bib30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jpba.2010.04.014","article-title":"Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptors","volume":"53","author":"Schepmann","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114359_bib31","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1021\/acs.jmedchem.0c01912","article-title":"Ifenprodil stereoisomers: synthesis, absolute configuration, and correlation with biological activity","volume":"64","author":"Bechthold","year":"2021","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114359_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-019-0645-6","article-title":"A common mechanism allows selective targeting of GluN2B subunit-containing N-Methyl-D-Aspartate receptors","volume":"2","author":"Schreiber","year":"2019","journal-title":"Commun. Biol."},{"issue":"15","key":"10.1016\/j.ejmech.2022.114359_bib33","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/cmdc.201800214","article-title":"Synthesis and pharmacological evaluation of enantiomerically pure GluN2B selective NMDA receptor antagonists","volume":"13","author":"B\u00f6rgel","year":"2018","journal-title":"ChemMedChem"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114359_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-2999(93)90241-9","article-title":"Further characterization of [3H]ifenprodil binding to \u03c3 receptors in rat brain","volume":"236","author":"Hashimoto","year":"1993","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114359_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0014-2999(94)00763-W","article-title":"Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of \u03c3 receptors","volume":"273","author":"Hashimoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114359_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/jlcr.3718","article-title":"Synthesis and pharmacological evaluation of fluorinated benzo[7]Annulen-7-amines as GluN2B-selective NMDA receptor antagonists","volume":"62","author":"Thum","year":"2019","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"29","key":"10.1016\/j.ejmech.2022.114359_bib37","doi-asserted-by":"crossref","first-page":"5407","DOI":"10.1039\/C4OB00510D","article-title":"Synthesis and pharmacological evaluation of like- and unlike-configured tetrahydro-2-benzazepines with the \u03b1-substituted benzyl moiety in the 5-position","volume":"12","author":"Hasebein","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2022.114359_bib38","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejmech.2014.06.073","article-title":"Synthesis and \u03c3 receptor affinity of regioisomeric spirocyclic furopyridines","volume":"83","author":"Miyata","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114359_bib39","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.bmc.2013.01.038","article-title":"Improvement of \u03a31 receptor affinity by late-stage C-H-bond arylation of spirocyclic lactones","volume":"21","author":"Meyer","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2022.114359_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cmdc.201700311","article-title":"Design, synthesis, pharmacological evaluation and docking studies of GluN2B-selective NMDA receptor antagonists with a benzo[7]Annulen-7-amine scaffold","volume":"12","author":"Gawaskar","year":"2017","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114359_bib41","series-title":"Modulators of CCR-5 Activity","author":"Boman","year":"2006"},{"issue":"32","key":"10.1016\/j.ejmech.2022.114359_bib42","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1002\/anie.201904861","article-title":"Nickel-catalyzed arylboration of alkenylarenes: synthesis of boron-substituted quaternary carbons and regiodivergent reactions","volume":"58","author":"Chen","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2022.114359_bib43","unstructured":"APEX 3. Bruker AXS Inc.: Madison, Wisconsin, USA 2019."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114359_bib44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT - integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. A Found. Crystallogr."},{"key":"10.1016\/j.ejmech.2022.114359_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."},{"key":"10.1016\/j.ejmech.2022.114359_bib46","series-title":"XP \u2013 Interactive Molecular Graphics","year":"1998"},{"key":"10.1016\/j.ejmech.2022.114359_bib47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ejmech.2017.12.054","article-title":"Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation","volume":"144","author":"Temme","year":"2018","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422002616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:42:18Z","timestamp":1759329738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422002616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":47,"alternative-id":["S0223523422002616"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114359","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of conformationally restricted GluN2B ligands derived from eliprodil","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114359"}}